And this requires a few more. It’s difficult to know how to apply robust trial data to older sicker patients so this international SENIOR registry study developed and validated artificial neural networks to reliably predict survival outcomes after head and neck chemoradiation in nearly 900 patients aged 65+, with meaningful additional data inputs including HPV status, renal function, ECOG status, and nodal stage. | Marschner, JAMA
